Inhibitory effects of rosemary extracts, carnosic acid and rosmarinic acid on the growth of various human cancer cell lines.
The leaves of Rosmarinus officinalis harvested from three different locations of Turkey were extracted by both methanolic and supercritical CO(2) extraction. Subsequently, six extracts and the active compounds, carnosic acid, and rosmarinic acid were applied to various human cancer cell lines including NCI-H82 (human, small cell lung, carcinoma), DU-145 (human, prostate, carcinoma), Hep-3B (human, black, liver, carcinoma, hepatocellular), K-562 (human chronic myeloid leukemia), MCF-7 (human, breast, adenocarcinoma), PC-3 (human, prostate, adenocarcinoma) and MDA-MB-231 (human, breast, adenocarcinoma) by MTT assay. Supercritical CO(2) extracts had superior antiproliferative effect compared to the soxhlet extracts. Although the extracts exhibited various cytotoxic effects against different cell lines, comparatively low IC(50) values ranging between 12.50 and 47.55 microg/ml were attained against K-562, being the most sensitive cell line. Moreover, carnosic acid caused the lowest cell viability with values ranging from 13 to 30 % at a concentration of 19 muM after 48 h of treatments, resulting in superior antiproliferative effect. Rosemary extract is a potential candidate to be included in the anti-cancer diet with pre-determined doses avoiding toxicity.
Yesil-Celiktas
Ozlem
O
Department of Bioengineering, Faculty of Engineering, Ege University, 35100, Bornova, Izmir, Turkey. ozlem.yesil.celiktas@ege.edu.tr
Sevimli
Canan
C
Bedir
Erdal
E
Vardar-Sukan
Fazilet
F
D045784:Abietanes / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use*; D000972:Antineoplastic Agents, Phytogenic / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use*; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects*; D002470:Cell Survival / Q000187:drug effects; D002934:Cinnamates / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use*; D053630:Depsides / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D020128:Inhibitory Concentration 50; D009369:Neoplasms / Q000188:drug therapy*; D008517:Phytotherapy; D010936:Plant Extracts / Q000737:chemistry / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use*; D027542:Rosmarinus / Q000737:chemistry*; D014421:Turkey; D000097123:Rosmarinic Acid
D045784:Abietanes; D000972:Antineoplastic Agents, Phytogenic; D002934:Cinnamates; D053630:Depsides; D010936:Plant Extracts; D000097123:Rosmarinic Acid; C018381:salvin
J Chromatogr A. 2000 Feb 18;870(1-2):491-9
10722107
Nephrol Dial Transplant. 2000 Aug;15(8):1140-5
10910436
Cancer Lett. 1996 Jun 24;104(1):43-8
8640744
Cancer Lett. 2010 Feb 28;288(2):183-91
19619938
Nutr Cancer. 2001;41(1-2):135-44
12094616
Cancer Lett. 2001 Sep 10;170(1):33-9
11448532
Cancer Res. 1994 Feb 1;54(3):701-8
8306331
Cancer Lett. 2002 Mar 28;177(2):145-53
11825661
J Chromatogr A. 2003 May 2;995(1-2):119-25
12800928
Carcinogenesis. 1995 Sep;16(9):2057-62
7554054
Bioorg Med Chem. 2003 Apr 17;11(8):1631-8
12659748
Cancer Lett. 1997 Mar 19;114(1-2):275-81
9103309
Cancer Lett. 2006 Jun 8;237(1):130-6
16019137
Cancer Lett. 1991 Nov;60(2):169-75
1933840
Plant Foods Hum Nutr. 1999;53(2):169-74
10472794
Biochem Pharmacol. 2005 Jan 15;69(2):221-32
15627474
Plant Foods Hum Nutr. 1997;50(1):47-53
9198114
Oncol Rep. 2007 Jun;17(6):1525-31
17487414